Smooth Muscle β Subunit of the Epithelial Na+ Channel Deletion Induces Moderate Hypertension and Renal Injury
Kidney360 · 2026-10 · 7 (10) · 2233-2248
DOI: 10.34067/kid.0000001306 ↗Abstract
Key Points Loss of pressure-induced constriction, independent of primary pathology, induces mild renal injury. Loss of pressure-induced constriction leads to vascular inflammation. Background Pressure-induced constriction (PIC) of renal arterial vasculature has been proposed to protect delicate glomerular capillaries from barotrauma. Previous studies from our laboratory have shown that degenerin proteins, including the β subunit of the epithelial Na + channel ( β ENaC), are important mediators of the PIC response. Methods We generated a smooth muscle β ENaC knockout mouse model (SMC- β ENaC −/− ) to determine the importance of smooth muscle β ENaC to the phenotype seen in β ENaC hypomorph mice. We assessed renal interlobar vascular reactivity using myography, renal inflammation and injury using histology, blotting, ELISA and flow cytometry, and BP using plethysmography. Results We found that vasoconstrictor agonist (potassium chloride, phenylephrine)–induced responses were similar in SMC- β ENaC −/− and control mice. However, PIC responses in the renal interlobar artery were abolished in SMC- β ENaC −/− mice. Systolic BP was measured by tail-cuff plethysmography from 6 to 26 weeks of age, and systolic BP was greater in SMC- β ENaC −/− male (139±2 versus 120.3±1 mm Hg) and female (134±0.8 versus 117.3±3) mice compared with control littermates. We also found mild glomerular injury in SMC- β ENaC −/− mice at 26 weeks. By 16 weeks of age, we found elevated levels of leukocytes, including M1/M2 macrophages, neutrophils, T cells, and B cells in renal arterial tissue in SMC- β ENaC −/− mice. Conclusions Our findings provide additional evidence that vascular smooth muscle cell β ENaC contributes to the transduction of the PIC response in renal vessels. Moreover, our findings provide evidence of the protective nature of PIC against vascular renal injury.
EUVIMED